Simtuzumab (LOXL2) - Research Grade Biosimilar
Product Specifications
Background
Simtuzumab has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.
Immunogen
Humanized / LOXL2 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-574
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
AB0024, GS-6624
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6161088-01 0.1 mL
WNK3 (Serine/threonine-protein Kinase WNK3, Protein Kinase Lysine-deficient 3, Protein Kinase with No Lysine 3, PRKWNK3, KIAA1566) (PE)
Ask
View Details MBS6161088-02 5x 0.1 mL
WNK3 (Serine/threonine-protein Kinase WNK3, Protein Kinase Lysine-deficient 3, Protein Kinase with No Lysine 3, PRKWNK3, KIAA1566) (PE)
Ask
View Details